Comparison between Avience Biomedicals IPO and Galaxy Medicare IPO.
IPO Details
Avience Biomedicals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Galaxy Medicare IPO is a SME Bookbuilding proposed to list at NSE SME.
The total issue size of Avience Biomedicals IPO is up to ₹0.00 Cr whereas the issue size of the Galaxy Medicare IPO is up to ₹21.19 Cr. The final issue price of Avience Biomedicals IPO is and of Galaxy Medicare IPO is ₹54.00 per share.
Avience Biomedicals IPO opens on , while Galaxy Medicare IPO opens on Sep 10, 2025. The closing date of Avience Biomedicals IPO and Galaxy Medicare IPO is , and Sep 12, 2025, respectively.
In the Avience Biomedicals IPO Retail Individual Investors (RII) are offered 0 shares while in Galaxy Medicare IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Avience Biomedicals IPO and 80,000 shares in Galaxy Medicare IPO.